Life science 2

BenevolentAI uses AI to accelerate biopharma drug discovery and provide life science intelligence. BenevolentAI (Euronext Amsterdam: BAI) is a company that applies advanced AI to accelerate biopharma drug discovery. Their next-generation platform targets the complex decisions that drive R&D, providing life science intelligence. They build technology in the service of science, bringing together science and technology teams to push AI and machine learning to new limits. They leverage their knowledge graph and proprietary ontologies to support scientists and executives in leveraging cutting-edge AI with confidence and precision.

Your AI Agents for Innovation. Execute your innovation workflows faster with domain-specific AI agents. Designed for intellectual property, R&D, materials science and life science, Patsnap Eureka provides dozens of domain-specific AI agents that can complete labor-intensive workflows in seconds, freeing experts to focus on high-impact decisions and technological innovation. Smart enough for scientists and secure enough for enterprises.